Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient-centred multidisciplinary care.

Addiction Anti-infective agents Bacterial infections Cardiovascular infections Harm reduction Substance abuse, intravenous Substance-related disorders

Journal

The Medical journal of Australia
ISSN: 1326-5377
Titre abrégé: Med J Aust
Pays: Australia
ID NLM: 0400714

Informations de publication

Date de publication:
18 07 2022
Historique:
revised: 18 05 2022
received: 20 01 2022
accepted: 30 05 2022
pubmed: 28 6 2022
medline: 20 7 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

There has been a global increase in the burden of invasive infections in people who inject drugs (PWID). It is essential that patient-centred multidisciplinary care is provided in the management of these infections to engage PWID in care and deliver evidence-based management and preventive strategies. The multidisciplinary team should include infectious diseases, addictions medicine (inclusive of alcohol and other drug services), surgery, psychiatry, pain specialists, pharmacy, nursing staff, social work and peer support workers (where available) to help address the comorbid conditions that may have contributed to the patient's presentation. PWID have a range of antimicrobial delivery options that can be tailored in a patient-centred manner and thus are not limited to prolonged hospital admissions to receive intravenous antimicrobials for invasive infections. These options include discharge with outpatient parenteral antimicrobial therapy, long-acting lipoglycopeptides (dalbavancin and oritavancin) and early oral antimicrobials. Open and respectful discussion with PWID including around harm reduction strategies may decrease the risk of repeat presentations with injecting-related harms.

Identifiants

pubmed: 35754144
doi: 10.5694/mja2.51623
pmc: PMC9539935
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-109

Informations de copyright

© 2022 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.

Références

Open Forum Infect Dis. 2017 Aug 26;4(4):ofx183
pubmed: 29026870
Am J Public Health. 2015 Dec;105(12):e53-9
pubmed: 26469651
Clin Infect Dis. 2019 May 17;68(11):1935-1937
pubmed: 30357363
J Antimicrob Chemother. 2019 Aug 1;74(8):2405-2416
pubmed: 31322694
Open Forum Infect Dis. 2019 Jan 30;6(2):ofz028
pubmed: 30838225
Circulation. 2015 Oct 13;132(15):1435-86
pubmed: 26373316
J Infect Dis. 2020 Sep 2;222(Suppl 5):S429-S436
pubmed: 32877563
Am J Med. 2022 Mar;135(3):369-379.e1
pubmed: 34715060
N Engl J Med. 2014 Jun 5;370(23):2169-79
pubmed: 24897082
Drugs. 2010 May 7;70(7):859-86
pubmed: 20426497
Antimicrob Agents Chemother. 2015;59(6):3365-72
pubmed: 25824211
Infect Dis Ther. 2019 Jun;8(2):171-184
pubmed: 31054088
Antimicrob Agents Chemother. 2004 Mar;48(3):940-5
pubmed: 14982787
Clin Infect Dis. 2020 Dec 17;71(10):e650-e656
pubmed: 32239136
Clin Infect Dis. 2018 Aug 16;67(5):795-798
pubmed: 29659732
Infection. 2019 Dec;47(6):1013-1020
pubmed: 31520397
Int J Antimicrob Agents. 2019 Nov;54(5):668-672
pubmed: 31400471
Open Forum Infect Dis. 2019 Jul 16;6(9):ofz308
pubmed: 31660397
Med J Aust. 2021 Jun;214(11):534-534.e1
pubmed: 34028813
JAMA Psychiatry. 2021 Sep 1;78(9):979-993
pubmed: 34076676
Clin Infect Dis. 2019 Sep 13;69(7):1120-1129
pubmed: 30590480
Am J Med. 2016 May;129(5):481-5
pubmed: 26597670
Open Forum Infect Dis. 2018 Jun 08;5(7):ofy132
pubmed: 30018999
BMJ Qual Saf. 2020 Apr;29(4):348-352
pubmed: 31888955
Int J Infect Dis. 2019 Apr;81:210-214
pubmed: 30794940
Drug Alcohol Depend. 2013 Jul 1;131(1-2):23-35
pubmed: 23490450
Clin Infect Dis. 2015 Sep 15;61(6):e26-46
pubmed: 26229122
Open Heart. 2017 Dec 27;4(2):e000699
pubmed: 29344368
J Am Coll Cardiol. 2019 Feb 12;73(5):559-570
pubmed: 30732709
Harm Reduct J. 2021 Feb 16;18(1):19
pubmed: 33593364
Soc Sci Med. 2014 Mar;105:59-66
pubmed: 24508718
J Antimicrob Chemother. 2010 Dec;65(12):2641-4
pubmed: 20864497
J Thorac Cardiovasc Surg. 2016 Sep;152(3):832-841.e1
pubmed: 27068439
Open Forum Infect Dis. 2018 Aug 07;5(9):ofy194
pubmed: 30211247
Ann Thorac Surg. 2021 Aug;112(2):573-581
pubmed: 33127400
Open Forum Infect Dis. 2019 Jun 05;6(7):ofz274
pubmed: 31281868
Clin Infect Dis. 2020 Jul 27;71(3):564-571
pubmed: 31504326
MMWR Recomm Rep. 2012 Nov 9;61(RR-5):1-40
pubmed: 23135062
Open Forum Infect Dis. 2017 May 23;4(3):ofx102
pubmed: 28680904
Open Forum Infect Dis. 2019 Jun 18;6(7):ofz289
pubmed: 31304193
J Addict Med. 2022 Jul-Aug 01;16(4):375-378
pubmed: 34510088
Harm Reduct J. 2019 Feb 13;16(1):16
pubmed: 30760261
Open Forum Infect Dis. 2022 Jan 06;9(2):ofab631
pubmed: 35097153
Drug Alcohol Rev. 2015 Mar;34(2):221-8
pubmed: 25521168
N Engl J Med. 2019 Jan 31;380(5):415-424
pubmed: 30152252
Cureus. 2017 Aug 18;9(8):e1579
pubmed: 29057191
PLoS Med. 2021 Oct 5;18(10):e1003759
pubmed: 34610017
Surg Infect (Larchmt). 2021 Oct;22(8):771-779
pubmed: 33835882
Psychosomatics. 2018 Sep - Oct;59(5):490-495
pubmed: 29685397
J Infect Dis. 2020 Sep 2;222(Suppl 5):S451-S457
pubmed: 32877550
Ann Clin Microbiol Antimicrob. 2019 Oct 19;18(1):30
pubmed: 31629409
BMJ. 2017 Apr 26;357:j1550
pubmed: 28446428
Int J Drug Policy. 2021 Oct;96:103421
pubmed: 34452808
BMC Pharmacol Toxicol. 2020 Oct 28;21(1):73
pubmed: 33115540
Open Forum Infect Dis. 2018 Dec 10;6(1):ofy331
pubmed: 30648126
N Engl J Med. 2019 Jan 31;380(5):425-436
pubmed: 30699315
BMJ Open. 2017 Apr 20;7(4):e013560
pubmed: 28428184
Open Forum Infect Dis. 2020 Jul 13;7(8):ofaa293
pubmed: 32793767
Open Forum Infect Dis. 2018 Apr 18;5(5):ofy056
pubmed: 29766017
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Swiss Med Wkly. 2020 Jun 21;150:w20259
pubmed: 32564343
Clin Infect Dis. 2019 Jan 1;68(1):e1-e35
pubmed: 30423035
J Gen Intern Med. 2010 Sep;25(9):926-9
pubmed: 20425146
Clin Infect Dis. 2013 Jan;56(1):e1-e25
pubmed: 23223583
Drug Alcohol Depend. 2020 Feb 1;207:107793
pubmed: 31874449
Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):575-580
pubmed: 30680563
J Gen Intern Med. 2017 Aug;32(8):909-916
pubmed: 28526932
Ann Thorac Surg. 2020 May;109(5):1426-1432
pubmed: 31630767
J Addict Med. 2020 Jul/Aug;14(4):282-286
pubmed: 31634202
J Subst Abuse Treat. 2016 Apr;63:1-9
pubmed: 26882891

Auteurs

Lucy O Attwood (LO)

Alfred Health, Melbourne, VIC.
Monash University, Melbourne, VIC.

Megan McKechnie (M)

Alfred Health, Melbourne, VIC.

Olga Vujovic (O)

Alfred Health, Melbourne, VIC.
Monash University, Melbourne, VIC.

Peter Higgs (P)

Burnet Institute, Melbourne, VIC.
La Trobe University, Melbourne, VIC.

Martyn Lloyd-Jones (M)

Alfred Health, Melbourne, VIC.

Joseph S Doyle (JS)

Alfred Health, Melbourne, VIC.
Monash University, Melbourne, VIC.
Burnet Institute, Melbourne, VIC.

Andrew J Stewardson (AJ)

Alfred Health, Melbourne, VIC.
Monash University, Melbourne, VIC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH